Plasma Levels of Long-Acting Injectable Antipsychotics in
Outpatient Care: A Retrospective Analysis

J 2021

Plasma Levels of Long-Acting Injectable Antipsychotics in Outpatient Care: A Retrospective Analysis

HYZA, M.; P. SILHAN; E. CESKOVA; T. SKRONT; I. KACIROVA et al.

Základní údaje

Originální název

Plasma Levels of Long-Acting Injectable Antipsychotics in Outpatient Care: A Retrospective Analysis

Autoři

HYZA, M.; P. SILHAN; E. CESKOVA; T. SKRONT; I. KACIROVA; R. URINOVSKA a M. GRUNDMANN

Vydání

Neuropsychiatric Disease and Treatment, New Zealand, Dove Medical Press, 2021, 1176-6328

Další údaje

Jazyk

angličtina

Typ výsledku

Článek v odborném periodiku

Obor

30230 Other clinical medicine subjects

Stát vydavatele

Česká republika

Utajení

není předmětem státního či obchodního tajemství

Odkazy

URL

Impakt faktor

Impact factor: 2.989

Označené pro přenos do RIV

Ano

Kód RIV

RIV/00216224:90128/21:00140071

Organizační jednotka

CZECRIN III

Klíčová slova česky

therapeutic drug monitoring; antipsychotics; psychotic disorders; schizophrenia

Klíčová slova anglicky

therapeutic drug monitoring; antipsychotics; psychotic disorders; schizophrenia

Štítky

Excelence Science, FN OSTRAVA, RIV, user

Příznaky

Mezinárodní význam, Recenzováno

Změněno: 30. 11. 2025 22:12, Bc. Hana Vladíková, BBA

Anotace

V originále

Purpose: Antipsychotic efficacy in schizophrenia depends on its availability in the body. Although therapeutic outcomes remain still far from satisfactory, therapeutic drug monitoring not a common part of clinical practice during treatment with long-acting injectable antipsychotics (LAI AP). The real effectiveness of LAI AP is thus uncertain. Patients and Methods: We made a retrospective evaluation of plasma levels of LAI AP. Collection of blood samples was performed just before the drug application and one week later. Forty patients with a stabilized clinical condition and steady-state plasma levels were included. Results: In the observed cohort of patients, flupentixol decanoate (n = 23) was the most often used drug, followed by fluphenazine decanoate (n = 7), haloperidol decanoate (n = 5), paliperidone palmitate (n = 3), and risperidone microspheres (n = 2). Just 5 of 40 patients were treated with a monotherapy. In the period before the application, 60% of the patients did not reach the therapeutic reference range (TRR) and 20% of the patients had an undetectable plasma level. At the time of collection of the second blood samples performed after 7 days, 24% of the patients were under the TRR. Conclusion: We have found a surprisingly high incidence of plasma levels under the TRR patients treated with LAI AP. Notwithstanding individual variability in pharmacokinetics, seems that LAI AP may be underdosed in usual clinical practice.

Návaznosti

90128, velká výzkumná infrastruktura

Název: CZECRIN III

Citovat

HYZA, M.; P. SILHAN; E. CESKOVA; T. SKRONT; I. KACIROVA; R. URINOVSKA a M. GRUNDMANN. Plasma Levels of Long-Acting Injectable Antipsychotics in Outpatient Care: A Retrospective Analysis. Neuropsychiatric Disease and Treatment. New Zealand: Dove Medical Press, 2021, roč. 17, NA, s. 1069-1075. ISSN 1176-6328. Dostupné z: https://doi.org/10.2147/NDT.S298050.

@article{1807988,
   author = {Hyza, M. and Silhan, P. and Ceskova, E. and Skront, T. and Kacirova, I. and Urinovska, R. and Grundmann, M.},
   article_location = {New Zealand},
   article_number = {NA},
   doi = {https://doi.org/10.2147/NDT.S298050},
   keywords = {therapeutic drug monitoring; antipsychotics; psychotic disorders; schizophrenia},
   language = {eng},
   issn = {1176-6328},
   journal = {Neuropsychiatric Disease and Treatment},
   title = {Plasma Levels of Long-Acting Injectable Antipsychotics in Outpatient Care: A Retrospective Analysis},
   url = {https://www.dovepress.com/plasma-levels-of-long-acting-injectable-antipsychotics-in-outpatient-c-peer-reviewed-fulltext-article-NDT},
   volume = {17},
   year = {2021}
}

TY  - JOUR
ID  - 1807988
AU  - Hyza, M. - Silhan, P. - Ceskova, E. - Skront, T. - Kacirova, I. - Urinovska, R. - Grundmann, M.
PY  - 2021
TI  - Plasma Levels of Long-Acting Injectable Antipsychotics in Outpatient Care: A Retrospective Analysis
JF  - Neuropsychiatric Disease and Treatment
VL  - 17
IS  - NA
SP  - 1069-1075
EP  - 1069-1075
PB  - Dove Medical Press
SN  - 11766328
KW  - therapeutic drug monitoring
KW  - antipsychotics
KW  - psychotic disorders
KW  - schizophrenia
UR  - https://www.dovepress.com/plasma-levels-of-long-acting-injectable-antipsychotics-in-outpatient-c-peer-reviewed-fulltext-article-NDT
N2  - Purpose: Antipsychotic efficacy in schizophrenia depends on its availability in the body. Although therapeutic outcomes remain still far from satisfactory, therapeutic drug monitoring not a common part of clinical practice during treatment with long-acting injectable antipsychotics (LAI AP). The real effectiveness of LAI AP is thus uncertain. Patients and Methods: We made a retrospective evaluation of plasma levels of LAI AP. Collection of blood samples was performed just before the drug application and one week later. Forty patients with a stabilized clinical condition and steady-state plasma levels were included. Results: In the observed cohort of patients, flupentixol decanoate (n = 23) was the most often used drug, followed by fluphenazine decanoate (n = 7), haloperidol decanoate (n = 5), paliperidone palmitate (n = 3), and risperidone microspheres (n = 2). Just 5 of 40 patients were treated with a monotherapy. In the period before the application, 60% of the patients did not reach the therapeutic reference range (TRR) and 20% of the patients had an undetectable plasma level. At the time of collection of the second blood samples performed after 7 days, 24% of the patients were under the TRR. Conclusion: We have found a surprisingly high incidence of plasma levels under the TRR patients treated with LAI AP. Notwithstanding individual variability in pharmacokinetics, seems that LAI AP may be underdosed in usual clinical practice.
ER  -

HYZA, M.; P. SILHAN; E. CESKOVA; T. SKRONT; I. KACIROVA; R. URINOVSKA a M. GRUNDMANN. Plasma Levels of Long-Acting Injectable Antipsychotics in Outpatient Care: A Retrospective Analysis. \textit{Neuropsychiatric Disease and Treatment}. New Zealand: Dove Medical Press, 2021, roč.~17, NA, s.~1069-1075. ISSN~1176-6328. Dostupné z: https://doi.org/10.2147/NDT.S298050.

Přehled o publikaci